1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Cefozopran - Comprehensive patent search

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information.

 
 
Global Markets Direct
Global Markets Direct
PRLog - Apr. 5, 2012 - Eliminate unnecessary risk with the industry benchmark in comprehensive patent information.

Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.

The Pipeline Developer report covers Cefozopran
Cefozopran indications: Treatment of bacterial infections and meningitis
Cefozopran innovator: Takeda (Firstcin, Firstein)

For Sample Pages, please click or add the below link to your browser:
http://www.globalmarketsdirect.com/SamplePdfRequest.aspx?...

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.

Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.

Pipeline Developer features:

- Comprehensive patent searching, covering the world's key territories (see 'search coverage' below)
- Identifies patents covering molecule, formulation, process, use, combination and assay techniques (see 'Patent Categories Identified'below)
- Patent identification, categorisation and interpretation
- Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims
- Manual filtration of patents not relevant to generic development
- Updated on a monthly basis, including changes to patent families, statuses, and litigation
- Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers

Patent Categories Identified:

1. Molecular Form
a) Molecule Patents
b) Salts, Hydrates & Solvates
c) Polymorphic Forms
d) Other Molecular Forms

2. Active Ingredient Preparation
a) Intermediates & Preparation Thereof
b) Final Synthetic Stages
c) Complete Synthesis
d) Purification Methods
e) Fermentation Methods
f) Biotechnology

3. Formulations & Methods Thereof
a) General Formulations & Methods
b) Injectable Formulations
c) Oral Formulations
d) Other Administration-Specific Formulations
e) Excipients, Kits & Packaging

4. Related Medical Use & Administration
a) New Use Related to Main Indication
b) Dosing Regimen/Administration Conditions

5. Active Ingredient Combinations
a) Novel Combinations
b) Use of Combinations
c) Dosing Regimen & Administration Conditions for Combinations

6. Analytical Methods
a) Assaying Methods
b) Methods of Determining Patient Suitability

Search coverage:
Clicking on a patent family displays detailed information on the 'Core' and 'Non-Core' 'Patent Family Equivalents'. 'Core Patent Family Equivalents' are equivalent patents from territories that are individually verified and monitored for changes, including British, German, Spanish, French, US, Canadian, Australian, European, and PCT patents. Statuses are also monitored and updated. 'Extended Patent Family Equivalents' are equivalent patents found through the INPADOC database, increasing the search coverage to 70 countries.

Patent and national register access:
Clicking on a listed patent/application number or text or image link will launch a pop-up window containing an image of the patent, enabling easy analysis of the patent documents. Clicking on a register link launches a pop-up window with the patent office register extract for that patent. This allows investigation into the examination status of a pending patent, opposition of a granted patent and/or payment of maintenance fees. Please note that no extra charges apply to accessing or downloading documents of any kind.

Litigation alerts:
Informing you of developments in court, litigation alerts can also be accessed by clicking on the litigation symbol next to the status, with links to judgements where available.

Updating:
To take the time and hassle out of monitoring and updating a large number of patents, all Pipeline Developer reporting is updated on a monthly basis. Convenient change flags identify new patent families, new patent family members, changes in statuses and litigation alerts.

Legal status and transaction history:
You can also find legal status and transaction history for 'Extended Patent Family Equivalents' by clicking on the INPADOC Family/Legal Status button for 65 additional territories.

Reporting and access:
All data can be exported into Microsoft Excel and print friendly versions for ease of data manipulation and reporting. Company details are confidential and all data is SSL secure. Five users per company are permitted and access levels are controlled by a nominated 'company administrator'.

Pipeline Developer is just one of the benchmark products from GenericsWeb's Pipeline Patent Intelligence product suite

For further details, please click or add the below link to your browser:
http://www.globalmarketsdirect.com/Report.aspx?ID=Guidebo...
Visit our Report Store
http://www.globalmarketsdirect.com

For more details contact:
pressreleases@globalmarketsdirect.com

Photo:
http://www.prlog.org/11842211/1

--- End ---

Click to Share

Contact Email:
***@globalmarketsdirect.com Email Verified
Source:rgunnam
Phone:+914066166782
Zip:EC4Y 0AN
State/Province:London - United Kingdom
Industry:Science
Tags:Cefozopran, pharmaceuticals_and_healthcare, Global Markets Direct
Shortcut:prlog.org/11842211
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share